These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25424871)

  • 1. Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone.
    Zhang P; Xi M; Zhao L; Li QQ; He LR; Liu SL; Shen JX; Liu MZ
    Radiat Oncol; 2014 Nov; 9():256. PubMed ID: 25424871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral cervical nodal metastasis is an independent prognostic factor for esophageal squamous cell carcinoma patients undergoing chemoradiotherapy: a retrospective study.
    Zhang P; Xi M; Zhao L; Li QQ; He L; Liu S; Shen J; Liu MZ
    PLoS One; 2014; 9(6):e101332. PubMed ID: 24979040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis.
    Li J; Gong Y; Diao P; Huang Q; Wen Y; Lin B; Cai H; Tian H; He B; Ji L; Guo P; Miao J; Du X
    Radiat Oncol; 2018 Jan; 13(1):12. PubMed ID: 29357883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.
    Jing Z; Chen T; Zhang X; Wu S
    Cancer Sci; 2017 Sep; 108(9):1828-1833. PubMed ID: 28665042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.
    Cho WK; Oh D; Ahn YC; Shim YM; Zo JI; Sun JM; Ahn MJ; Park K
    Oncotarget; 2017 Jan; 8(2):3542-3552. PubMed ID: 27682879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy.
    Liu H; Lu L; Zhu Q; Hao Y; Mo Y; Liu M; Hu Y; Cui N; Rong T
    Radiother Oncol; 2011 May; 99(2):181-6. PubMed ID: 21620504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide Study.
    Chao YK; Chen HS; Wang BY; Hsu PK; Liu CC; Wu SC
    Ann Thorac Surg; 2016 May; 101(5):1897-902. PubMed ID: 26912307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
    Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.
    Lu JC; Tao H; Chen ZZ; Qian PD
    Dis Esophagus; 2009; 22(6):490-5. PubMed ID: 19191849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
    Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
    Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
    Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
    Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional hyperthermia combined with radiotherapy for esophageal squamous cell carcinoma with supraclavicular lymph node metastasis.
    Sheng L; Ji Y; Wu Q; Du X
    Oncotarget; 2017 Jan; 8(3):5339-5348. PubMed ID: 28029663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma.
    Hamai Y; Hihara J; Emi M; Furukawa T; Ibuki Y; Yamakita I; Kurokawa T; Okada M
    Anticancer Res; 2017 Oct; 37(10):5639-5646. PubMed ID: 28982881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
    Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
    Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.
    Chen J; Su T; Lin Y; Wang B; Li J; Pan J; Chen C
    Clin Transl Oncol; 2018 Mar; 20(3):411-419. PubMed ID: 28779422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
    Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C
    BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.
    Zheng YZ; Zhao W; Hu Y; Ding-Lin XX; Wen J; Yang H; Liu QW; Luo KJ; Huang QY; Chen JY; Fu JH
    World J Gastroenterol; 2015 Jul; 21(28):8644-52. PubMed ID: 26229406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-radical chemoradiotherapy for 53 esophageal squamous cell carcinomas with supraclavicular lymph node metastasis in a single institutional retrospective study.
    Yamashita M; Takenaka HY; Nakagawa K
    Hepatogastroenterology; 2014 Oct; 61(135):1971-8. PubMed ID: 25713897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern.
    Bao Y; Liu S; Zhou Q; Cai P; Anfossi S; Li Q; Hu Y; Liu M; Fu J; Rong T; Li Q; Liu H
    Radiat Oncol; 2013 Oct; 8():241. PubMed ID: 24139225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.